Abstract

The vascular effect of salvigenin (6-hydroxyapigenin 6,7,4′-trimethyl ether) ( 1) , a natural flavone, was investigated in comparison with another flavone, 6-hydroxyluteolin 6,7,3′,4′-tetramethyl ether ( 2) in rat aotic rings. Cumulative addition of their increasing concentrations (10 − 9 –10 − 4 M) produced graded relaxations on rings precontracted with noradrenaline (10 − 6 M) and KCl (40 mM). The maximal relaxations induced by flavones were similar, however, based on their pEC 50 values salvigenin displayed a higher potency than 6-hydroxyluteolin 6,7,3′,4′-tetramethyl ether. Endothelium removal markedly reduced the relaxations to salvigenin while the responses to 6-hydroxyluteolin 6,7,3′,4′-tetramethyl ether were partially affected. In addition, a significant decrease was observed in maximal responsiveness and sensitivity to flavones in the presence of l-NOARG, a NO synthase inhibitor. The cyclooxygenase inhibitor indomethacin significantly inhibited the relaxations to salvigenin, but not altered the responses to 6-hydroxyluteolin 6,7,3′,4′-tetramethyl ether. Our results provide evidence that salvigenin is an effective flavone in causing vasorelaxation which appears to be mediated by endothelium derived NO and prostacyclin. Whereas, the other flavone, 6-hydroxyluteolin 6,7,3′,4′-tetramethyl ether induced relaxant responses are partially endothelium, presumably NO mediated.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.